Recently, accumulating evidence suggests that NEAT1 acts as tumor-promoting in the occurrence and development of most tumors, such as breast cancer [19], multiple myeloma [20], and pancreatic cancer [21]. This evidence concerns the gene NEAT1 and plasma cell myeloma.